Risdiplam is the only orally administered drug accepted for the cure of SMA. It was FDA permitted in 2020 to be used in patients two months of age and more mature, and it capabilities as an SMN2 gene splicing modifier leading to increased levels of SMN protein. Oral administration is https://jackg297waf9.humor-blog.com/profile